NDC:59338-775-01活性物质:FERUMOXYTOL剂量:510 mg/ 17 mL服用方式:静脉注射NDA:NDA022180 首次上市时间:07/13/2009分销商:AMAG Pharmaceuticals, Inc.生产商一:Baxter Pharmaceutical Solutions生产商二:Patheon Manufacturing Services LLC说明书:PDF
药品编号 06349838 持证商 MCM KLOSTERFRAU Vertr. GmbH 包装规格 100 St Packungsnorm N3 产品名 Soledum Kapseln 100mg 剂型 Kapseln magensaftresistent Monopräparat ja 活性物质 Cineol 需要医生开处方 nein Apothekenpflichtig ja 信息来源:https://www.besamex.de/produkt/soledum-100-mg-magensaftresistente-kapseln-100-st-06349838.html
产品名称:HADLIMA上市时间:04/26/2023NDA/ANDA/BLA:761059持证商:SAMSUNG BIOEPIS CO LTDNDC:0006-5032-02,0006-5031-02说明书:https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761059s000lbl.pdf批准信:https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/761059Orig1s000ltr.pdf
产品名称:TRIKAFTA (COPACKAGED)上市时间:04/26/2023NDA/ANDA/BLA:217660持证商:VERTEX PHARMS INCNDC:51167-445-01,51167-446-01说明书:https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217660s000lbl.pdf批准信:https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/217660orig1s000ltr.pdf
产品名称:DEXAMETHASONE上市时间:04/26/2023NDA/ANDA/BLA:217538持证商:BIONPHARMA INCNDC:说明书:批准信:
产品名称:THEOPHYLLINE上市时间:04/26/2023NDA/ANDA/BLA:216300持证商:BIONPHARMA INCNDC:说明书:批准信:
产品名称:LIVTENCITY上市时间:04/26/2023NDA/ANDA/BLA:215596持证商:TAKEDA PHARMS USANDC:64764-800-28,64764-800-56说明书:https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215596lbl.pdf批准信:https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/215596Orig1s000ltr.pdf
产品名称:ZEJUL上市时间:04/26/2023NDA/ANDA/BLA:214876持证商:GLAXOSMITHKLINENDC:0173-0909-13,0173-0912-13,0173-0915-13说明书:https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214876s000lbl.pdf批准信:https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/214876Orig1s000ltr.pdf
产品名称:CLOBAZAM上市时间:04/26/2023NDA/ANDA/BLA:214404持证商:AUROBINDO PHARMA LTDNDC:59651-401-12说明书:https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?setid=1b5749a1-1c6d-4243-a833-4bfd84f9d5a9&type=pdf批准信:
产品名称:CLOBAZAM上市时间:04/26/2023NDA/ANDA/BLA:213039持证商:ALKEM LABS LTDNDC:67877-658-61说明书:批准信:
产品名称:TRIKAFTA (COPACKAGED)上市时间:04/26/2023NDA/ANDA/BLA:212273持证商:VERTEX PHARMS INCNDC:51167-106-02,51167-331-01说明书:https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212273s000lbl.pdf批准信:https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/212273Orig1s000ltr.pdf